GLILogo Xl

Pan-society Presentation of NAFLD Nomenclature Consensus Process

In early 2021, a global effort was established to explore the appropriateness and ramifications of a potential re-naming of Nonalcoholic Fatty Liver Disease (NAFLD). In addition to evaluating the current name, if the process determined that a change was appropriate, a key additional goal is to consider which replacement term would best reflect our evolving understanding of the pathophysiology of NAFLD while allowing for the incorporation of future knowledge. In considering the nomenclature, the consensus process sought to better understand the impact of stigma and awareness on patients and caregivers globally.

Over the last two years, a group of 264 global experts from 56 countries have participated in multiple survey rounds utilizing the delphi process. Additionally, a group of 122 participants (54% of survey respondents) from 32 countries participated in an interactive Nomenclature Summit in Chicago, USA in July 2022 to discuss and evaluate the results of the first two delphi rounds. This project has been supported by more than a dozen professional societies and patient groups around the world.

The purpose of this session is to update attendees on the process and key findings of this Delphi process and to engage in discussion with the global community.

GLI CEO Donna Cryer, JD, will be among presenters at this presentation.

Join live from anywhere on YouTube.


Nov 06 2022


3:00 pm - 5:00 pm


Ballroom ABC